Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

by Monica Gerson, Benzinga Staff Writer

April 2, 2014 4:29 AM | 28 seconds read | Make a Comment

Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio. PDL BioPharma

PDLI

has a PEG ratio of 0.35. PDL BioPharma's trailing-twelve-month revenue is $442.90 million. Enzymotec

ENZY

has a PEG ratio of 0.43. Enzymotec's trailing-twelve-month operating margin is 18.20%. Questcor Pharmaceuticals

QCOR

has a PEG ratio of 0.50. Questcor Pharma's trailing-twelve-month EPS is $4.73. INSYS Therapeutics

INSY

has a PEG ratio of 1.05. INSYS Therapeutics' trailing-twelve-month ROE is 165%.

Posted In: Trading Ideas Biotechnology Industry NASDAQ PEG ratio

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.